Alessandro Bartolomucci Selected Research

Complement C3a (Complement 3a)

9/2019	Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.
1/2017	The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Bartolomucci Research Topics

Disease

14	Obesity 08/2021 - 11/2011
8	Body Weight (Weight, Body) 08/2021 - 07/2010
3	Hypertension (High Blood Pressure) 01/2022 - 10/2016
3	Neoplasms (Cancer) 12/2021 - 04/2007
3	Hyperphagia (Overeating) 08/2021 - 08/2011
2	Cardiotoxicity 01/2022 - 01/2018
2	Heart Failure 01/2022 - 01/2018
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 05/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2016
2	Pain (Aches) 12/2011 - 08/2008
1	Dementia (Dementias) 01/2022
1	Hypertrophy 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Muscle Weakness 11/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Inflammation (Inflammations) 10/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016
1	Hyperglycemia 10/2016
1	Insulin Resistance 01/2016
1	Facioscapulohumeral Muscular Dystrophy 01/2016
1	Insulinoma 06/2015
1	Glucose Intolerance 05/2015
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2015
1	Dyslipidemias (Dyslipidemia) 12/2013
1	Fibrosis (Cirrhosis) 01/2012
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2012
1	Lymphopenia (Lymphocytopenia) 04/2007
1	Infections 09/2004

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2011
6	Peptides (Polypeptides)IBA 01/2017 - 08/2008
3	Angiotensin IIIBA 01/2022 - 10/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2018
3	NeuropeptidesIBA 08/2021 - 01/2017
3	CorticosteroneIBA 01/2021 - 07/2010
3	LeptinIBA 05/2015 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2011
2	Blood Glucose (Blood Sugar)IBA 08/2021 - 10/2016
2	DystrophinIBA 05/2020 - 11/2018
2	LipidsIBA 01/2020 - 01/2016
2	Complement C3a (Complement 3a)IBA 09/2019 - 01/2017
2	ChromograninsIBA 01/2013 - 12/2011
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	doxorubicin-DNAIBA 12/2021
1	DNA AdductsIBA 12/2021
1	Peptide Receptors (Peptide Receptor)IBA 09/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	ResveratrolIBA 01/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	CytokinesIBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Leptin ReceptorsIBA 05/2015
1	AdiponectinIBA 12/2013
1	chromogranin A (344-364)IBA 01/2013
1	Chromogranin AIBA 01/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2012
1	Muscarinic M2 ReceptorIBA 01/2012
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2012
1	Serotonin (5 Hydroxytryptamine)IBA 01/2012
1	Neuropeptide YIBA 11/2011
1	Sildenafil Citrate (Viagra)FDA Link 01/2011
1	Messenger RNA (mRNA)IBA 08/2008
1	Formaldehyde (Formol)FDA Link 08/2008
1	AntigensIBA 04/2007
1	Immunoglobulin G (IgG)IBA 04/2007
1	Tuberculin (PPD)IBA 09/2004
1	Interleukin-10 (Interleukin 10)IBA 09/2004

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
2	Therapeutics 12/2021 - 01/2017
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2015
1	Controlled Hypotension 01/2021
1	Fat-Restricted Diet (Diet, Fat Restricted) 10/2016
1	Denervation 10/2016